Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Imipenem”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02452047
What this trial is testing

Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)

Who this might be right for
Bacterial Infections
Merck Sharp & Dohme LLC 50
Not applicableStudy completedNCT00443885
What this trial is testing

Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC

Who this might be right for
Gram Negative Organism
University of Pittsburgh 500
Not applicableEnded earlyNCT06929585
What this trial is testing

Genicular Artery Embolization (GAE) vs inTra-articular Corticosteroid Injection for Osteoarthritic Knee Pain.

Who this might be right for
Osteoarthritis (OA) of the Knee
National Taiwan University Hospital 1
Large-scale testing (Phase 3)Study completedNCT00081744
What this trial is testing

Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects

Who this might be right for
Gram-Positive Bacterial InfectionsCross Infection
Wyeth is now a wholly owned subsidiary of Pfizer 850
Post-approval studies (Phase 4)UnknownNCT01356472
What this trial is testing

Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia

Who this might be right for
Methicillin-resistant Staphylococcus AureusPneumonia, Ventilator-Associated
Ruijin Hospital 60
Large-scale testing (Phase 3)Study completedNCT00136201
What this trial is testing

Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections

Who this might be right for
Abdominal Abscess
Wyeth is now a wholly owned subsidiary of Pfizer 200
Large-scale testing (Phase 3)Study completedNCT02493764
What this trial is testing

Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)

Who this might be right for
Bacterial Pneumonia
Merck Sharp & Dohme LLC 537
Large-scale testing (Phase 3)Study completedNCT00236834
What this trial is testing

The Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization

Who this might be right for
Nosocomial Pneumonia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 438
Not applicableStudy completedNCT01714570
What this trial is testing

Piperacillin/Tazobactam for Empirical Therapy of Febrile Neutropenia

Who this might be right for
FebrileNeutropeniaHematopoietic Stem Cell Transplantation
Chinese PLA General Hospital 123
Post-approval studies (Phase 4)Study completedNCT02897206
What this trial is testing

Imipenem Prophylaxis in Patients With Acute Pancreatitis

Who this might be right for
Acute Pancreatitis
University Hospital Rijeka 98
Testing effectiveness (Phase 2)Study completedNCT02321800
What this trial is testing

Efficacy and Safety of Intravenous Cefiderocol (S-649266) Versus Imipenem/Cilastatin in Complicated Urinary Tract Infections

Who this might be right for
Urinary Tract Infections
Shionogi 452
Large-scale testing (Phase 3)Study completedNCT05887908
What this trial is testing

Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in Subjects With Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis

Who this might be right for
Complicated Urinary Tract InfectionAcute PyelonephritiscUTI+1 more
Meiji Seika Pharma Co., Ltd. 614
Large-scale testing (Phase 3)Study completedNCT03293485
What this trial is testing

Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017)

Who this might be right for
Complicated Intra-abdominal InfectionComplicated Urinary Tract Infection
Merck Sharp & Dohme LLC 83
Post-approval studies (Phase 4)WithdrawnNCT05146154
What this trial is testing

Impact of Obesity on the Pharmacokinetics of Imipenem-Relebactam in ICU Patients

Who this might be right for
ObesityCritical Illness
University of Illinois at Chicago
Testing effectiveness (Phase 2)Study completedNCT01506271
What this trial is testing

Study of the Safety, Tolerability, and Efficacy of Relebactam (MK-7655) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone to Treat Complicated Intra-Abdominal Infection [cIAI] (MK-7655-004)

Who this might be right for
Intra-abdominal Infections
Merck Sharp & Dohme LLC 351
Large-scale testing (Phase 3)Study completedNCT05204563
What this trial is testing

Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, REITAB-2)

Who this might be right for
Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia
Evopoint Biosciences Inc. 450
Testing effectiveness (Phase 2)Ended earlyNCT00707239
What this trial is testing

Study Evaluating Safety and Efficacy of Tigecycline Versus Imipenem/Cilastatin Subjects With Hospital-Acquired Pneumonia

Who this might be right for
Pneumonia, Bacterial
Pfizer 108
Post-approval studies (Phase 4)Ended earlyNCT02474706
What this trial is testing

Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli

Who this might be right for
Urinary Tract Infections
Central Hospital, Nancy, France 6
Not applicableUnknownNCT05516433
What this trial is testing

Effect of Imipenem and Meropenem on the Digestive Microbiota and the Emergence and Carriage of Multidrug-resistant Bacteria

Who this might be right for
Enterobacteriaceae Infections
Fondation Hôpital Saint-Joseph 100
Not applicableUnknownNCT06173440
What this trial is testing

Management of an Imipenem-resistant Acinetobacter Baumannii Alert in a French University Hospital

Who this might be right for
Acinetobacter Baumannii
University Hospital, Strasbourg, France 148
Next Page